HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply.

AuthorsSteven M Greenberg, Rustam Al-Shahi Salman, Geert Jan Biessels, Mark van Buchem, Charlotte Cordonnier, Jin-Moo Lee, Joan Montaner, Julie A Schneider, Eric E Smith, Meike Vernooij, David J Werring
JournalThe Lancet. Neurology (Lancet Neurol) Vol. 13 Issue 6 Pg. 540 (Jun 2014) ISSN: 1474-4465 [Electronic] England
PMID24849857 (Publication Type: Letter, Comment)
Chemical References
  • Biomarkers
Topics
  • Biomarkers
  • Cerebral Amyloid Angiopathy (pathology, therapy)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: